We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Ruxolitinib and Lenalidomide for Patients With Myelofibrosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01375140
Recruitment Status : Active, not recruiting
First Posted : June 17, 2011
Last Update Posted : June 27, 2017
Incyte Corporation
Information provided by (Responsible Party):
M.D. Anderson Cancer Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : September 2018
  Estimated Study Completion Date : September 2018